Stavros Vizirgianakis reached a letter agreement with Apyx Medical Corporation (APYX)

Key Summary: On April 1, 2024, Stavros G. Vizirgianakis (5.04%) announced plans to engage with management and the board. On May 7, 2024, Stavros Vizirgianakis (5.04%) joined the board, filling a vacancy and becoming Chair, following a letter agreement with the company. On April 5, 2024, Strategos Fund/Archon Capital Management (9.9%) announced its ongoi…